Connect with us

Business

Imugene (ASX:IMU) share price jumps 8% on FDA update

Published

on

Image source: Getty Images

The Imugene Limited (ASX: IMU) share price is on course to end the week on a positive note.

In morning trade, the clinical stage immuno-oncology company’s shares are up 8.5% to 38 cents.

This latest gain means the Imugene share price is now up 280% in…



Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending